[Off-label use of Budesonide suspensions to treat a patient with lymphocytic esophagitis].
Sign Up to like & getrecommendations! Published in 2017 at "Zeitschrift fur Gastroenterologie"
DOI: 10.1055/s-0043-117187
Abstract: Background Lymphocytic esophagitis (LyE) is a rare chronic inflammatory disease of the esophagus, which shares clinical characteristics with the eosinophilic esophagitis. The most important part of its treatment is proton pump inhibitors (PPIs). Referring to locally… read more here.
Keywords: esophagitis; treatment; label use; lymphocytic esophagitis ... See more keywords
Lymphocytic esophagitis updated
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the New York Academy of Sciences"
DOI: 10.1111/nyas.14001
Abstract: I read with interest “Lymphocytic esophagitis: an update on histologic diagnosis, endoscopic findings, and natural history,” by Patil et al.1 The authors stated that lymphocytic esophagitis (LyE) is characterized by increased intraepithelial lymphocytes (IELs) (>20/high-power… read more here.
Keywords: cd3; lye; eoe; esophagitis ... See more keywords
Lymphocytic esophagitis: Still an enigma a decade later
Sign Up to like & getrecommendations! Published in 2017 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v23.i6.949
Abstract: Lymphocytic esophagitis (LE) is a clinicopathologic entity first described by Rubio et al in 2006. It is defined as peripapillary intraepithelial lymphocytosis with spongiosis and few or no granulocytes on esophageal biopsy. This definition is… read more here.
Keywords: esophagitis still; still enigma; decade later; esophagitis ... See more keywords